skip to main content


Shareholder Information

Major Shareholdings

Major shareholder Number of shares Percentage holding
North West Fund (Biomedical) LP 16,186,446 22.1%
RisingStars Growth Fund LP II 11,950,869 16.3%
AXA Framlington Investment Management Limited 6,785,000 9.3%
South Yorkshire Investment Fund Limited 3,772,949 5.2%
Seneca Partners Limited 3,536,022 4.8%
Sarum Investment SICAV Plc 3,005,053 4.1%
Letzone Limited 2,664,000 3.6%
Beaufort Securities Limited 2,457,568 3.4%

There are 73,272,591 ordinary shares in issue
This page was last updated on 20 March 2017

Notice of AGM

A copy of the 2017 AGM notice is available at this link. The 2017 AGM corporate presentation can be viewed at this link.

Advisers and Registrars

Nominated Adviser and Broker: Northland Capital Partners Limited
60 Gresham Street, London,  EC2V 7BB

Solicitors: Pinsent Masons LLP 

Pinsent Masons LLP, 30 Crown Place, London, EC2A 4EN

Auditors: RSM UK Audit LLP
9th Floor, 3 Hardman Street, Manchester, M3 3HF

Reporting Accounts: RSM UK Group LLP

25 Farringdon Street, London, EC4A 4AB

Technical Expert: PharmaVentures Ltd
Triumph House, Parkway Court, Oxford Business Park, Oxford, OX4 2JY

Patent Attorney: HGF Ltd
17-19 Whitworth St West, Manchester, M1 5WG

Financial Public Relations: Buchanan
107 Cheapside, London, EC2V 6DN

Registrars: SLC Registrars
Division of Equiniti David Venus Ltd, 42-50 Hersham Road, Walton on Thames, Surrey, KT12 1RZ